₹ 1,022.91 Cr
0.21%
NIFTY Pharma TRI
INF204KC1089
1000.0
0.0
100
Jitendra Tolani
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Nippon India Nifty Pharma ETF | 5.44 | 21.15 | - |
| Nifty Pharma TRI | 5.67 | 21.48 | 15.01 |
Equity
Debt
Others
The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 22.18 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 10.65 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 10.51 |
| Dr. Reddys Laboratories Ltd | 9.08 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 5.91 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.64 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 4.61 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 3.97 |
| ALKEM LABORATORIES LIMITED EQ | 3.86 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 3.55 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.97 |
| Scheme Name | 5Y (%) |
|---|---|
| Nippon India Nifty Pharma ETF | 0.0 |
| HDFC Silver ETF Gr | 0.0 |
| ICICI Pru Silver ETF | 0.0 |
| ABSL Silver ETF | 0.0 |
| DSP Silver ETF | 0.0 |
| Axis Silver ETF | 0.0 |
| Mirae Asset Silver ETF | 0.0 |
| Kotak Silver ETF | 0.0 |
| SBI Silver ETF | 0.0 |
| Nippon India Silver ETF | 0.0 |